Eli Lilly (NYSE: LLY) has been around for almost 150 years, finding ways to innovate and grow. Today, it's the most valuable ...

We believe there is minimal cause for concern with LLY stock, which makes it attractive but highly sensitive to adverse events as its current valuation is extremely ...

Both of these products quickly became blockbusters and, along with drugs from Novo Nordisk, dominate the market. All of this ...

Eli Lilly (NYSE:LLY) recently announced several significant events, including promising trial results for baricitinib in ...

Parnassus Core Equity Fund sees Eli Lilly And Co. (NYSE:LLY) as a strong long-term investment due to its GLP-1 franchise and ...

Learn More » All of this has helped Lilly's revenue climb in the double digits in recent quarters and the stock price to take off. The shares have advanced more than 200% over the past three years.

Eli Lilly (NYSE: LLY) stock defied today's market ... It's as simple as that -- and good enough for a 2.6% stock price bump. The Motley Fool Stock Advisor analyst team just identified what they ...

Eli Lilly's stock is undervalued; defensive healthcare stocks shine amid uncertainty, and Eli Lilly drives growth. Click here ...

Stock splits tend to create a lot of buzz in the market, especially when some of the most prominent companies announce a ...